Recently, we reported that BMP9 is a crucial factor inducing the malignant nature of HCC and found that BMP9-ID1 signaling promotes cancer stem cell properties in EpCAM-positive HCC cells by activating Wnt/β-catenin signaling [9]. The gene discussed is GDF2; the disease is hepatocellular carcinoma.